Page 20 - 2022-27-中国全科医学
P. 20
http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn ·3345·
Outcome Study[J]. Lancet Diabetes Endocrinol,2019,7(6): areas for integrated prevention and control in Guiyang[J]. Modern
452-461. DOI:10.1016/S2213-8587(19)30093-2. Preventive Medicine,2021,48(11):2067-2069,2099.
[31]MA J,WAN X,WU B. The cost-effectiveness of lifestyle [40]国家卫生健康委员会 . 中国卫生健康统计年鉴(2020)[M].
interventions for preventing diabetes in a health resource-limited 北京:中国协和医科大学出版社,2020.
setting[J]. J Diabetes Res,2020,2020:7410797. DOI: National Health Commission. China health statistical yearbook,
10.1155/2020/7410797. 2020[M]. Beijing:People Union Medical College Publishing
[32]ZHANG L X,ZHAO M H,ZUO L,et al. China kidney disease House,2020.
network(CK-NET)2016 annual data report[J]. Kidney Int [41]ZHONG Q,GAO Y,ZHENG X,et al. Geographic variation in
Suppl(2011),2020,10(2):e97-185. DOI:10.1016/j. process and outcomes of care for patients with acute myocardial
kisu.2020.09.001. infarction in China from 2001 to 2015[J]. JAMA Netw Open,
[33]LI Y R,ZHAO L Y,YU D M,et al. Metabolic syndrome 2020,3(10):e2021182. DOI:10.1001/jamanetworkop
prevalence and its risk factors among adults in China:a nationally en.2020.21182.
representative cross-sectional study[J]. PLoS One,2018,13(6): [42]ATKINS E R,DU X,WU Y F,et al. Use of cardiovascular
e0199293. DOI:10.1371/journal.pone.0199293. prevention treatments after acute coronary syndrome in China and
[34]何宇纳,赵文华,赵丽云,等 . 2010—2012 年中国 10~17 岁 associated factors[J]. Int J Cardiol,2017,241:444-449.
儿童青少年代谢综合征流行情况[J]. 中华预防医学杂志, DOI:10.1016/j.ijcard.2017.03.057.
2017,51(6):513-518. [43]HU Z,CHEN S P,DU J Z,et al. An in-hospital mortality risk
HE Y N,ZHAO W H,ZHAO L Y,et al. The epidemic status of model for patients undergoing coronary artery bypass grafting in
metabolic syndrome among Chinese adolescents aged 10- 17 years in China[J]. Ann Thorac Surg,2020,109(4):1234-1242.
2010-2012[J]. Chinese Journal of Preventive Medicine,2017, DOI:10.1016/j.athoracsur.2019.08.020.
51(6):513-518. [44]GBD 2019 Stroke Collaborators. Global,regional,and national
[35]LIANG F C,XIAO Q Y,HUANG K Y,et al. The 17-y burden of stroke and its risk factors,1990-2019:a systematic
spatiotemporal trend of PM 2.5 and its mortality burden in analysis for the Global Burden of Disease Study 2019 [J]. Lancet
China[J]. Proc Natl Acad Sci USA,2020,117(41):25601- Neurol,2021,20(10):795-820. DOI:10.1016/S1474-
25608. DOI:10.1073/pnas.1919641117. 4422(21)00252-0.
[36]LIU C,YIN P,CHEN R J,et al. Ambient carbon monoxide and [45]XIA F,YU X X,LI Y K,et al. Geographic variations of stroke
cardiovascular mortality:a nationwide time-series analysis in 272 incidence in Chinese communities:an 18-year prospective cohort
cities in China[J]. Lancet Planet Health,2018,2(1):e12- study from 1997 to 2015[J]. J Stroke,2020,22(3):345-
18. DOI:10.1016/S2542-5196(17)30181-X. 356. DOI:10.5853/jos.2020.02383.
[37]张爽,张辉,沈成凤,等 . 2008—2018 年天津市慢病示范区期 [46]WANG W Z,JIANG B,SUN H X,et al. Prevalence,
望寿命与主要慢病死亡水平分析[J]. 疾病监测,2020,35(6): incidence,and mortality of stroke in China:results from a
495-502. DOI:10.3784/j.issn.1003-9961.2020.06.009. nationwide population-based survey of 480 687 adults[J].
ZHANG S,ZHANG H,SHEN C F,et al. Life expectancy and Circulation,2017,135(8):759-771. DOI:10.1161/CIRCUL
mortality rates of major chronic disease in demonstration area of ATIONAHA.116.025250.
Tianjin,2008-2018[J]. Disease Surveillance,2020,35(6): [47]WANG Z W,CHEN Z,WANG X,et al. The disease burden
495-502. DOI:10.3784/j.issn.1003-9961.2020.06.009. of atrial fibrillation in China from a national cross-sectional
[38]丁贤彬,毛德强,唐文革,等 . 重庆市慢性病综合防控示范区 survey[J]. Am J Cardiol,2018,122(5):793-798. DOI:
与非示范区主要慢性病早死概率趋势变化分析[J]. 中国慢性 10.1016/j.amjcard.2018.05.015.
病 预 防 与 控 制,2018,26(10):725-729. DOI:10.16386/j. [48]GUO J,GUAN T J,FAN S Y,et al. Underuse of oral
cjpccd.issn.1004-6194.2018.10.002. anticoagulants in patients with ischemic stroke and atrial fibrillation
DING X B,MAO D Q,TANG W G,et al. Trend analysis of the in China[J]. Am J Cardiol,2018,122(12):2055-2061.
premature death probability of major chronic non-communicable DOI:10.1016/j.amjcard.2018.08.057.
diseases between demonstration areas and non-demonstration areas [49]CHANG S S,DONG J Z,MA C S,et al. Current status and
in Chongqing city[J]. Chinese Journal of Prevention and Control of time trends of oral anticoagulation use among Chinese patients
Chronic Diseases,2018,26(10):725-729. DOI:10.16386/j. with nonvalvular atrial fibrillation:the Chinese atrial fibrillation
cjpccd.issn.1004-6194.2018.10.002. registry study[J]. Stroke,2016,47(7):1803-1810. DOI:
[39]蒲焱,潘春柳,杨珂维,等 . 贵阳市慢性病综合防控示范区 10.1161/STROKEAHA.116.012988.
居民重点慢性病死亡及早死概率分析[J]. 现代预防医学, [50]HUA W,ZHANG L F,WU Y F,et al. Incidence of sudden
2021,48(11):2067-2069,2099. cardiac death in China:analysis of 4 regional populations[J]. J
PU Y,PAN C L,YANG K W,et al. Analysis on the death and Am Coll Cardiol,2009,54(12):1110-1118. DOI:10.1016/j.
early death probability for four main NCDs about the demonstration jacc.2009.06.016.